Data Bridge Market Research analyses a growth rate in the global pertussis market in the forecast period 2022-2029.
By employing several steps, gathering, analysing and recording of market data has been carried out in this
Pertussis market report. To formulate this report, systematic, objective and exhaustive study of the facts related to any subject in the field of marketing have been performed. Not to mention, various purposes or objectives of market research are kept in mind while forming the Pertussis report which helps client achieve success in the business. The report helps businesses to take on the approach of systematic problem analysis, model building and fact-finding that ultimately aids in decision-making and managing marketing of goods and services.
Data Bridge Market Research analyses a growth rate in the global pertussis market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Overview:
Pertussis is a highly contagious respiratory disease causes by Bordetella pertussis, a bacteria that lives in nose, mouth and throat. It is also called as whooping cough. Infants children are at major risk for the infection and spread easily from person to person through droplets produced by coughing or sneezing. Initial symptoms generally appear after 7-10 days of infection which includes rainy nose, mild fever cough, other symptoms are pneumonia (common), pneumonia, encephalopathy (rare). Pertussis infection can be prevented by immunization/vaccination.
Key players operating in the global pertussis market include:
Merck KGaA (Germany)
Novartis AG (Switzerland)
Mylan N.V. (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Sanofi (France)
Novartis AG (Switzerland)
Sun Pharmaceutical Industries Ltd. (India)
Aurobindo Pharma (India)
GSK plc (U.K.)
F. Hoffmann-La Roche Ltd. (Switzerland)
AstraZeneca (UK)
Lilly (U.S.)
Drivers
Increased Cases of Whooping Cough:
Increasing Air Pollution
Increasing Demand for Retail Pharmacies
Lack of skilled professionals
The huge expenditure associated with pertussis medications surely hamper the market growth.
The rising prevalence of whooping cough led to the market growth expansion. As per the reports of the World Health Organization (WHO), in 2018, there were about 151,000 cases of pertussis all over the globe. Thus, it boosts the market growth.
Opportunities
As per the World Bank data records, around 95% of deaths are caused by air pollution that occur in low- and middle- income countries in the year 2019. Additionally, the trend of unhealthy lifestyle such as lack of physical exercise, smoking, and direct or indirect presence of chemicals are expected to boost the market growth in the future. This creates more opportunity to the market.
The rise in the number of perinatal infections therapeutics being delivered through retail pharmacies and the increase in the number of retail pharmacies in highly developed countries create great opportunities for the market expansion. Additionally, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
Restraints/Challenges
The lack of healthcare professionals who cannot treat the patients with appropriate treatments could curb the growth of the global pertussis market over a forecast period.
High Cost
This global pertussis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global pertussis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Highlights of TOC:
Chapter 1: Market overview
Chapter 3: Regional analysis of the Global Pertussis Market industry
Chapter 4: Pertussis Market segmentation based on types and applications
Chapter 5: Revenue analysis based on types and applications
Chapter 6: Market share
Chapter 7: Competitive Landscape
Chapter 8: Drivers, Restraints, Challenges, and Opportunities
Chapter 9: Gross Margin and Price Analysis
Browse Trending Reports link:
About Data Bridge Market Research:
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475